JENNISON ASSOCIATES LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q1 2019$1,003,000
-84.6%
252,708
-84.5%
0.00%
-85.7%
Q4 2018$6,498,000
-59.6%
1,632,646
-30.1%
0.01%
-53.3%
Q3 2018$16,072,000
+2.7%
2,335,989
+0.7%
0.02%0.0%
Q2 2018$15,655,000
+4.9%
2,319,255
+1.2%
0.02%0.0%
Q1 2018$14,926,000
+68.1%
2,292,752
+14.9%
0.02%
+66.7%
Q4 2017$8,877,000
-27.3%
1,994,768
+1.0%
0.01%
-25.0%
Q3 2017$12,203,000
-33.7%
1,974,636
-0.5%
0.01%
-40.0%
Q2 2017$18,406,000
-38.3%
1,985,496
-38.3%
0.02%
-37.5%
Q1 2017$29,853,000
+10.9%
3,216,8810.0%0.03%
+6.7%
Q4 2016$26,925,000
+30.4%
3,216,881
+7.1%
0.03%
+36.4%
Q3 2016$20,641,000
+40.3%
3,004,521
+1.1%
0.02%
+37.5%
Q2 2016$14,714,000
+14.6%
2,972,606
+123.6%
0.02%
+23.1%
Q1 2016$12,841,000
+101.3%
1,329,345
+95.2%
0.01%
+116.7%
Q4 2015$6,380,000
-41.1%
680,877
-11.6%
0.01%
-45.5%
Q3 2015$10,829,000
-32.8%
770,232
+0.5%
0.01%
-26.7%
Q2 2015$16,115,000
+177.3%
766,279
+453.6%
0.02%
+200.0%
Q1 2015$5,811,000138,4180.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders